Ziegler J L, Klein G, Henle W
Int J Cancer. 1976 Jun 15;17(6):701-6. doi: 10.1002/ijc.2910170603.
Twenty American patients with Burkitt's lymphoma (BL) were studied serologically and biochemically to detect an association with Epstein-Barr virus (EBV). A wide range of antibody reactivities was encountered. Five patients had serological profiles similar to those of African patients with BL: one and possibly two of these patients harbored EBV-DNA in their tumors. Fifteen patients had low or absent antibody to EBV: tumors from 10 of these patients lacked evidence of EBV-DNA. An unexplained association between elevated antibody (greater than or equal to 1:80) to EBV virus capsid antigen (VCA) and a favorable prognosis was noted in this series; this prognostic observation requires further substantiation. Thus, it appears that EBV-associated BL is inversely proportional to tumor endemicity. An etiological role for EBV in BL remains speculative.
对20例美国伯基特淋巴瘤(BL)患者进行了血清学和生化研究,以检测与爱泼斯坦-巴尔病毒(EBV)的关联。发现了广泛的抗体反应性。5例患者的血清学特征与非洲BL患者相似:其中1例可能2例患者的肿瘤中含有EBV-DNA。15例患者对EBV的抗体水平低或缺乏:其中10例患者的肿瘤缺乏EBV-DNA的证据。在本系列研究中,观察到EBV病毒衣壳抗原(VCA)抗体升高(大于或等于1:80)与良好预后之间存在无法解释的关联;这一预后观察需要进一步证实。因此,似乎EBV相关的BL与肿瘤地方性呈反比。EBV在BL中的病因作用仍具有推测性。